Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.57p
   
  • Change Today:
    -0.020p
  • 52 Week High: 2.61p
  • 52 Week Low: 0.85p
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 609,628
  • Market Cap: £6.54m
  • RiskGrade: 328
  • Beta: 0.70

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £23,369
Lisa Baderoon 583,963 £9,168
Tim Franklin 525,000 £8,242

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 41,620,407 £653,440
Luca & Associates AG 22,000,000 £345,400
Invesco Ltd 17,872,341 £280,596
Aviva Investors Global 11,285,180 £177,177
Alora Pharmaceuticals LLC 10,909,091 £171,273
M&G Investments 7,600,000 £119,320
Prudential plc 7,600,000 £119,320
Capital Income Builder 4,870,367 £76,465
Dr R Zimmer 4,551,553 £71,459
Odey Asset Management 3,433,319 £53,903
Rhone Trustees (Switzerland) SA 3,386,000 £53,160
Pictet Overseas Trust Corporation Limited 3,287,500 £51,614

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.57p
Change Today -0.020p
% Change -1.26 %
52 Week High 2.61p
52 Week Low 0.85p
Volume 609,628
Shares Issued 416.44m
Market Cap £6.54m
Beta 0.70
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.47% below the market average71.47% below the market average71.47% below the market average71.47% below the market average71.47% below the market average
28% below the sector average28% below the sector average28% below the sector average28% below the sector average28% below the sector average
Price Trend
51.45% below the market average51.45% below the market average51.45% below the market average51.45% below the market average51.45% below the market average
6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:35 21,199 @ 1.57p
16:35 18,466 @ 1.57p
16:35 2,733 @ 1.57p
16:04 27,602 @ 1.56p
11:56 25,000 @ 1.60p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page